Leading Progress in Ending TB
Each year on March 24, CDC joins the global community to observe World Tuberculosis (TB) Day – an important moment to unite in support, attention, and energy to end TB. Although preventable and treatable, TB remains one of the world’s deadliest infectious diseases, taking the lives of 1.6 million people annually. With nearly 11 million people becoming ill with TB in 2021, this disease continues to prove that a threat of TB anywhere is a threat everywhere.
The theme for this year’s observance, ”Yes! We Can End TB,” highlights the determination and enthusiasm of global partners as we join forces to end the global TB epidemic. CDC is on the frontlines in 25 countries with high TB prevalence. Partnering with ministries of health, CDC is sustaining efforts to diagnose, cure, and prevent this disease. On World TB Day, CDC joins our global partners in affirming our commitment to ending TB– creating a safer America and world.
An overview of the TB burden among children and adolescents and CDC’s response.
This animated infographic describes what’s needed to address the serious challenge of multidrug resistant and extensively drug resistant TB.
CDC By the Numbers
Statement from CDC leaders on progress toward HIV epidemic control.
Antiretroviral Treatment for Men, Women, and Children**
PEPFAR: 18.9 Million
CDC: 11.8 Million
Voluntary Medical Male Circumcisions (VMMC)****
PEPFAR: 27.7 Million
CDC: 14.3 Million
People Who Received a Positive HIV Test Result***
PEPFAR: 2.5 Million
CDC: 1.5 Million
HIV-Positive Persons Screened in Care for TB***
PEPFAR: 15.5 Million
CDC: 9.5 Million
Antiretroviral Treatment to Prevent Mother-to-child Transmission***
*Other USG agencies may have also contributed to some of these achievements **As of Sept 30, 2021 ***FY2021 ****Cumulative through Sept 30, 2021
A message from CDC Director Rochelle Walensky, MD, MPH, on World TB Day.
Click here for the full message
Global TB Elimination Champions
CDC recognizes global organizations, individuals, and initiatives that have made significant contributions to ending TB. Click on the drop-down links below for more information on their unique contributions toward eliminating TB.
For her leadership in strengthening the programmatic management of DR-TB in India, we recognize Dr. Uma Devi as a TB Elimination Champion.
Pictured: Dr. Uma Devi
Since 2017, with CDC support, FIT and IRD VN have conducted nearly 1,100 community-based screening events and provided X-ray screening and Xpert testing to over 255,000 people in 10 Vietnam provinces. As a result, approximately 1,800 individuals were diagnosed with TB and given access to lifesaving treatment. FIT also piloted and scaled innovative public-private strategies, during which over 766,000 adults and children were screened, 15,106 persons with TB were detected, and 8,300 cases from outside the Vietnam National TB Program were notified. FIT’s work did not stop during the COVID-19 pandemic, as they continued to inform national guidance and continue the critical recovery of TB services.
For their continued contributions and dedication to ending TB in Vietnam, we recognize FIT as TB Elimination Champions.
Pictured: Dr. Thuc Ngo, FIT staff, positioning a participant during a CDC-supported screening campaign in remote mountainous areas using the novel ultra-portable X-ray system.
During her time at Partners in Health, Talina has led multiple community campaigns to provide information, screenings, and ultimately an early diagnosis of TB – even partnering with traditional healers to ensure timely TB diagnosis and treatment. Through her efforts, and despite challenges, Talinia and her team at Partners in Health have screened over 10,500 PLHIV for TB and treated approximately 1,500 patients, including approximately 100 patients with MDR TB.
For her continued contributions and dedication to ending TB in Haiti, we recognize Yoldine Talina Jean Noël as a TB Elimination Champion.
Pictured: Yoldine Talina Jean Noël
For her continued contributions and steadfast leadership in ending TB in Uganda, we recognize Dr. Turyahabwe Stavia as a TB Elimination Champion.
Pictured: Dr. Turyahabwe Stavia
For their unwavering commitment to science, tuberculosis elimination, and, above all, to the population they serve, we recognize Ivan Doan, Roksolana Kulchynska, Ezra Barzilay, Nataliya Podolchak, Yevenhi Lysenko, and Larysa Hartman as TB Elimination Champions.
Pictured from left to right: Ivan Doan, Roksolana Kulchynska, Ezra Barzilay, and Nataliya Podolcha
As CDC-Uganda’s sole TB public health specialist, Dr. Deus Lukoye, tirelessly works to stop TB among people living with HIV. Through his unique approach, founded on public health diplomacy, diverse stakeholder engagement, data-driven decision-making, and strategic science, Dr. Lukoye has been relentless in expanding CDC’s efforts to end TB in Uganda. His impact is featured in a first-authored article on the huge scale-up of TB preventive therapy (TPT) in Uganda in Emerging Infectious Diseases. This study demonstrated that TPT coverage among PLHIV increased from less than 1 percent in October 2016 to 89 percent in March 2022.
In South Africa, Katlego Motlhaoleng serves as a TB/HIV public health specialist providing technical guidance to the South African National Department of Health and PEPFAR District Support Partners on the development, implementation, and monitoring of TB/HIV program activities designed to improve patient health outcomes. Her reach in ending TB extends to the policy level, where she contributed to the development and approval of the Targeted Universal TB Testing guidelines and the revised TPT guidelines. Katelgo’s efforts have improved PEPFAR-supported programs through a 36 percent year-over-year increase in TB case finding, achieving the 1st and 2nd UNAIDS goals in TB/HIV programming in FY22- Q4, and increasing the year-over-year TPT completion by 4 percent.
For their vital role in the TB and TB/HIV efforts, Katlego Motlhaoleng and Dr. Deus Lukoye are recognized as TB Elimination Champions.
Pictured: Dr. Deus Lukoye and Katlego Motlhaoleng
Placing People at the Center of our Work
CDC is on the frontlines in some of the world’s highest-burden regions, working to understand what’s driving the spread of TB, including drug-resistant TB, and how to stop it. In India, a country with one of the highest burdens of drug-resistant TB in the world, CDC developed comprehensive, person-centered interventions to improve treatment outcomes in Mumbai’s Dharavi slum where historically less than half of individuals diagnosed with drug-resistant TB complete their treatment. Efforts included support to help clients adhere to taking their medication, monitoring for adverse events, and providing services to help link those who relocated to continued care. As a result of CDC-supported interventions, 88 percent of current drug-resistant TB patients in Dharavi remain on or have completed treatment as of January 2023.
Learn more about CDC’s impact and how the use of individualized approaches ensures that those who need care receive it.
Success Years in the Making
Through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), CDC is spearheading efforts to address the historical gaps in providing lifesaving TB Preventive Treatment (TPT) to those at increased risk of getting TB– particularly children and people living with HIV.
Each year, in Uganda, nearly 30,000 people living with HIV will develop active TB disease. But there is hope, as a recent CDC analysis of PEPFAR data shows Uganda is stopping the spread of HIV-associated TB by providing lifesaving TPT to people living with HIV. By providing TPT at both HIV and TB clinics and leveraging partnerships with the Ministry of Health, Uganda saw a dramatic increase from less than 1 percent of eligible people receiving TPT in 2016 to nearly 90 percent in 2022. Through this dynamic approach, more people are accessing lifesaving treatment and staying in care, with TPT completion rates more than tripling during the six-year period.
Learn more about these milestones in Emerging Infectious Diseases or listen below as Dr. Deus Lukoye, an epidemiologist at CDC, discusses the impact of TPT among people living with HIV in Uganda.
CDC’s Impact Around the Globe
Learn how CDC and partners are adapting services and expanding key treatment and prevention activities to end TB.
CDC’s Division of Global HIV & TB offers the following resources, which can be shared across various networks.
Shareable social media graphics that highlight key information in the fight against global TB.
Learn how CDC is leading the way in evidence-based TB interventions toward ending the TB epidemic worldwide.
CDC is engaging with communities across the United States to sustain impact in areas disproportionately affected by TB through capacity-building efforts like the TB Elimination Alliance, and the communications campaign Think. Test. Treat TB. aimed at raising awareness of TB prevention and promoting testing for and treatment of latent TB infection.